請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41344
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 符文美 | |
dc.contributor.author | Wei-Lan Yeh | en |
dc.contributor.author | 葉威蘭 | zh_TW |
dc.date.accessioned | 2021-06-15T00:16:18Z | - |
dc.date.available | 2009-09-15 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-06-05 | |
dc.identifier.citation | Abbott NJ, Ronnback L and Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41-53.
Ahima RS, Bjorbaek C, Osei S and Flier JS (1999) Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology 140(6):2755-2762. Ala-aho R and Kahari VM (2005) Collagenases in cancer. Biochimie 87(3-4):273-286. Allavena P, Sica A, Solinas G, Porta C and Mantovani A (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66(1):1-9. Andriopoulou P, Navarro P, Zanetti A, Lampugnani MG and Dejana E (1999) Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol 19(10):2286-2297. Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W and Dimmler A (2007) TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer 7:156. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, Moizo L, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y and Lewin MJ (1998) The stomach is a source of leptin. Nature 394(6695):790-793. Balkwill F, Charles KA and Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7(3):211-217. Balkwill F and Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539-545. Baltrons MA and Garcia A (1999) Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells. J Neurochem 73(5):2149-2157. Barthel A, Okino ST, Liao J, Nakatani K, Li J, Whitlock JP, Jr. and Roth RA (1999) Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J Biol Chem 274(29):20281-20286. Bazan JF, Timans JC and Kastelein RA (1996) A newly defined interleukin-1? Nature 379(6566):591. Belayev L, Busto R, Zhao W and Ginsberg MD (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739(1-2):88-96. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H and Seino S (1990) Molecular biology of mammalian glucose transporters. Diabetes Care 13(3):198-208. Bernotiene E, Palmer G and Gabay C (2006) The role of leptin in innate and adaptive immune responses. Arthritis Res Ther 8(5):217. Bjorbaek C, Uotani S, da Silva B and Flier JS (1997) Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272(51):32686-32695. Boran MS and Garcia A (2007) The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes. J Neurochem 102(1):216-230. Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P and van der Wall E (2005) Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46(1):31-36. Bove K, Neumann P, Gertzberg N and Johnson A (2001) Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 280(5):L914-922. Brader S and Eccles SA (2004) Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 90(1):2-8. Brooks PC, Clark RA and Cheresh DA (1994a) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264(5158):569-571. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G and Cheresh DA (1994b) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79(7):1157-1164. Brown C, Pan X and Hassid A (1999) Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. Circ Res 84(6):655-667. Brown RS and Wahl RL (1993) Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72(10):2979-2985. Carmeliet P (2002) Integrin indecision. Nat Med 8(1):14-16. Carmeliet P and Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249-257. Castellucci M, De Matteis R, Meisser A, Cancello R, Monsurro V, Islami D, Sarzani R, Marzioni D, Cinti S and Bischof P (2000) Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod 6(10):951-958. Chien WL, Liang KC, Teng CM, Kuo SC, Lee FY and Fu WM (2005) Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1. Eur J Neurosci 21(6):1679-1688. Chun YS, Yeo EJ and Park JW (2004) Versatile pharmacological actions of YC-1: anti-platelet to anticancer. Cancer Lett 207(1):1-7. Chung JK, Lee YJ, Kim SK, Jeong JM, Lee DS and Lee MC (2004) Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer. Nucl Med Commun 25(1):11-17. Cifone MA (1982) In vitro growth characteristics associated with benign and metastatic variants of tumor cells. Cancer Metastasis Rev 1(4):335-347. Condeelis J and Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263-266. Connolly DT (1991) Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 47(3):219-223. Cui H, Cai F and Belsham DD (2006) Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1/2, and p38 through c-Fos and ATF1. FASEB J 20(14):2654-2656. D'Souza SE, Ginsberg MH, Burke TA, Lam SC and Plow EF (1988) Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 242(4875):91-93. D'Souza SE, Ginsberg MH and Plow EF (1991) Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends Biochem Sci 16(7):246-250. De S, Razorenova O, McCabe NP, O'Toole T, Qin J and Byzova TV (2005) VEGF-integrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci U S A 102(21):7589-7594. Dejana E (2004) Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5(4):261-270. Dicou E, Attoub S and Gressens P (2001) Neuroprotective effects of leptin in vivo and in vitro. Neuroreport 12(18):3947-3951. Dinarello CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20(5 Suppl 27):S1-13. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Muhl H, Yoon DY, Reznikov LL, Kim SH and Rubinstein M (1998) Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 63(6):658-664. Dormond O and Ruegg C (2003) Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A. Thromb Haemost 90(4):577-585. Duelli R and Kuschinsky W (2001) Brain glucose transporters: relationship to local energy demand. News Physiol Sci 16:71-76. Dvorak HF, Brown LF, Detmar M and Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146(5):1029-1039. Egan RA and Vijayan VK (1991) Fibronectin immunoreactivity in neural trauma. Brain Res 568(1-2):330-334. Egeblad M and Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161-174. El Homsi M, Ducroc R, Claustre J, Jourdan G, Gertler A, Estienne M, Bado A, Scoazec JY and Plaisancie P (2007) Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways. Am J Physiol Gastrointest Liver Physiol 293(1):G365-373. Eliceiri BP and Cheresh DA (2001) Adhesion events in angiogenesis. Curr Opin Cell Biol 13(5):563-568. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y and Fujii-Kuriyama Y (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 94(9):4273-4278. Ezhilarasan R, Mohanam I, Govindarajan K and Mohanam S (2007) Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process. Int J Oncol 30(3):701-707. Fagan SC, Hess DC, Hohnadel EJ, Pollock DM and Ergul A (2004) Targets for vascular protection after acute ischemic stroke. Stroke 35(9):2220-2225. Faller DV (1999) Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 26(1):74-84. Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R and Friedman JM (1997) Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A 94(13):7001-7005. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C and Stahel PF (2005) IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 28(9):487-493. Feldkamp MM, Lau N, Rak J, Kerbel RS and Guha A (1999) Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 81(1):118-124. Feldman GJ, Mullin JM and Ryan MP (2005) Occludin: structure, function and regulation. Adv Drug Deliv Rev 57(6):883-917. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18(1):4-25. Ferrara N, Gerber HP and LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669-676. Fischer S, Clauss M, Wiesnet M, Renz D, Schaper W and Karliczek GF (1999) Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 276(4 Pt 1):C812-820. Flier JS, Mueckler MM, Usher P and Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235(4795):1492-1495. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16(9):4604-4613. Frankenberry KA, Somasundar P, McFadden DW and Vona-Davis LC (2004) Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 188(5):560-565. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J and Lopez-Otin C (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269(24):16766-16773. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA and Cheresh DA (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270(5241):1500-1502. Friedman JM and Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395(6704):763-770. Frisch SM and Ruoslahti E (1997) Integrins and anoikis. Curr Opin Cell Biol 9(5):701-706. Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R and Cheresh DA (1998) Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 4(11):2625-2634. Gehlsen KR, Argraves WS, Pierschbacher MD and Ruoslahti E (1988) Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol 106(3):925-930. Giordano D, Magaletti DM and Clark EA (2006) Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19. Blood 107(4):1537-1545. Gleadle JM, Ebert BL, Firth JD and Ratcliffe PJ (1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 268(6 Pt 1):C1362-1368. Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R and Frei K (2001) Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev 36(2-3):258-264. Gonzalez-Mariscal L, Betanzos A and Avila-Flores A (2000) MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol 11(4):315-324. Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J and Hood N (2005) Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 23(25):6037-6042. Gorin F, Harley W, Schnier J, Lyeth B and Jue T (2004) Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft. Acta Neuropathol 107(3):235-244. Gould GW and Holman GD (1993) The glucose transporter family: structure, function and tissue-specific expression. Biochem J 295 ( Pt 2):329-341. Graeber MB, Scheithauer BW and Kreutzberg GW (2002) Microglia in brain tumors. Glia 40(2):252-259. Grivennikov S and Karin M (2008) Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13(1):7-9. Grobben B, De Deyn PP and Slegers H (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310(3):257-270. Grover-McKay M, Walsh SA, Seftor EA, Thomas PA and Hendrix MJ (1998) Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res 4(2):115-120. Guo W and Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5(10):816-826. Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz SH, Bodian C, Slater G, Weiss A and Burstein DE (1998) GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83(1):34-40. Hanisch UK and Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10(11):1387-1394. Harik SI and Roessmann U (1991) The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors. Ann Neurol 29(5):487-491. Hawkins BT and Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57(2):173-185. Herholz K, Pietrzyk U, Voges J, Schroder R, Halber M, Treuer H, Sturm V and Heiss WD (1993) Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 79(6):853-858. Hiraki Y, Rosen OM and Birnbaum MJ (1988) Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 263(27):13655-13662. Hood JD and Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2(2):91-100. Hsing AW, Sakoda LC and Chua S, Jr. (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86(3):s843-857. Hsu HK, Juan SH, Ho PY, Liang YC, Lin CH, Teng CM and Lee WS (2003) YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway. Biochem Pharmacol 66(2):263-271. Hynes RO (2003) Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113(7):821-823. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, Kim NS, Yie SW, Byeon WH, Eom SH, Ha KS, Kim YM and Kim PH (2007) Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81(2):557-566. Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W, Zhu Y, Qiu Z, Qian X and He F (2003) Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3(5):724-737. John GR, Chen L, Rivieccio MA, Melendez-Vasquez CV, Hartley A and Brosnan CF (2004) Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci 24(11):2837-2845. Jung MK, Song HK, Kim KE, Hur DY, Kim T, Bang S, Park H and Cho DH (2006) IL-18 enhances the migration ability of murine melanoma cells through the generation of ROI and the MAPK pathway. Immunol Lett 107(2):125-130. Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3(6):422-433. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441(7092):431-436. Ke Q, Kluz T and Costa M (2005) Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line. Int J Environ Res Public Health 2(1):10-13. Kim HL, Yeo EJ, Chun YS and Park JW (2006a) A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Int J Oncol 29(1):255-260. Kim J, Kim C, Kim TS, Bang SI, Yang Y, Park H and Cho D (2006b) IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem Biophys Res Commun 344(4):1284-1289. Kim KW, Bae SK, Lee OH, Bae MH, Lee MJ and Park BC (1998) Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 58(2):348-351. Kim YJ, Hwang SY, Hwang JS, Lee JW, Oh ES and Han IO (2008) C6 glioma cell insoluble matrix components enhance interferon-gamma-stimulated inducible nitric-oxide synthase/nitric oxide production in BV2 microglial cells. J Biol Chem 283(5):2526-2533. Kim YJ, Hwang SY, Oh ES, Oh S and Han IO (2006c) IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J Neurosci Res 84(5):1037-1046. Kimball PM and Brattain MG (1980) Isolation of a cellular subpopulation from a human colonic carcinoma cell line. Cancer Res 40(5):1574-1579. Kinashi T (2005) Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 5(7):546-559. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW and Burger PC (1995) Histopathology, classification, and grading of gliomas. Glia 15(3):211-221. Ko FN, Wu CC, Kuo SC, Lee FY and Teng CM (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84(12):4226-4233. Kohyama M, Saijyo K, Hayasida M, Yasugi T, Kurimoto M and Ohno T (1998) Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18. Jpn J Cancer Res 89(10):1041-1046. Kurose I, Wolf R, Grisham MB and Granger DN (1994) Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 74(3):376-382. Leivonen SK, Ala-Aho R, Koli K, Grenman R, Peltonen J and Kahari VM (2006) Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 25(18):2588-2600. Leybaert L (2005) Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? J Cereb Blood Flow Metab 25(1):2-16. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M and Zafarullah M (2003) Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 288(1):208-217. Lin EY, Gouon-Evans V, Nguyen AV and Pollard JW (2002) The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7(2):147-162. Liu Y, Cox SR, Morita T and Kourembanas S (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res 77(3):638-643. Lo EH, Dalkara T and Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4(5):399-415. Lu DY, Liou HC, Tang CH and Fu WM (2006) Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 72(8):992-1000. Macheda ML, Rogers S and Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202(3):654-662. Madri JA and Pratt BM (1986) Endothelial cell-matrix interactions: in vitro models of angiogenesis. J Histochem Cytochem 34(1):85-91. Mahesparan R, Read TA, Lund-Johansen M, Skaftnesmo KO, Bjerkvig R and Engebraaten O (2003) Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 105(1):49-57. Mantovani A, Allavena P, Sica A and Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436-444. Mark KS, Burroughs AR, Brown RC, Huber JD and Davis TP (2004) Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. Am J Physiol Heart Circ Physiol 286(1):H174-180. Mark KS and Davis TP (2002) Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282(4):H1485-1494. Matsui H, Motooka M, Koike H, Inoue M, Iwasaki T, Suzuki T, Kurabayashi M and Yokoyama T (2007) Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sci 80(7):672-680. Merrill MJ and Oldfield EH (2005) A reassessment of vascular endothelial growth factor in central nervous system pathology. J Neurosurg 103(5):853-868. Micallef MJ, Tanimoto T, Kohno K, Ikeda M and Kurimoto M (1997) Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res 57(20):4557-4563. Milner R and Campbell IL (2003) The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol 170(7):3850-3858. Moldobaeva A, Welsh-Servinsky LE, Shimoda LA, Stephens RS, Verin AD, Tuder RM and Pearse DB (2006) Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 290(5):L919-930. Moon HS, Lee HG, Seo JH, Chung CS, Guo DD, Kim TG, Choi YJ and Cho CS (2007) Leptin-induced matrix metalloproteinase-2 secretion is suppressed by trans-10,cis-12 conjugated linoleic acid. Biochem Biophys Res Commun 356(4):955-960. Morash B, Johnstone J, Leopold C, Li A, Murphy P, Ur E and Wilkinson M (2000) The regulation of leptin gene expression in the C6 glioblastoma cell line. Mol Cell Endocrinol 165(1-2):97-105. Morash B, Li A, Murphy PR, Wilkinson M and Ur E (1999) Leptin gene expression in the brain and pituitary gland. Endocrinology 140(12):5995-5998. Murakami T, Nishiyama T, Shirotani T, Shinohara Y, Kan M, Ishii K, Kanai F, Nakazuru S and Ebina Y (1992) Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J Biol Chem 267(13):9300-9306. Murakami T, Yamashita T, Iida M, Kuwajima M and Shima K (1997) A short form of leptin receptor performs signal transduction. Biochem Biophys Res Commun 231(1):26-29. Neeman M and Degani H (1989) Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy. Cancer Res 49(3):589-594. Nishikawa T, Akiyama N, Kunimasa K, Oikawa T, Ishizuka M, Tsujimoto M and Natori S (2006) Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine. Eur J Pharmacol 539(3):151-157. Nishioka T, Oda Y, Seino Y, Yamamoto T, Inagaki N, Yano H, Imura H, Shigemoto R and Kikuchi H (1992) Distribution of the glucose transporters in human brain tumors. Cancer Res 52(14):3972-3979. Ohno S, Im HJ, Knudson CB and Knudson W (2006) Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes. J Biol Chem 281(26):17952-17960. Okada Y, Copeland BR, Hamann GF, Koziol JA, Cheresh DA and del Zoppo GJ (1996) Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol 149(1):37-44. Patel B, Khaliq A, Jarvis-Evans J, McLeod D, Mackness M and Boulton M (1994) Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem Mol Biol Int 34(3):639-644. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R and Larson SM (1985) Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62(6):816-822. Pearse DB, Shimoda LA, Verin AD, Bogatcheva N, Moon C, Ronnett GV, Welsh LE and Becker PM (2003) Effect of cGMP on lung microvascular endothelial barrier dysfunction following hydrogen peroxide. Endothelium 10(6):309-317. Pekala P, Marlow M, Heuvelman D and Connolly D (1990) Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 265(30):18051-18054. Plata-Salaman CR (1991) Epidermal growth factor and the nervous system. Peptides 12(3):653-663. Plate KH, Breier G, Weich HA and Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359(6398):845-848. Plate KH and Mennel HD (1995) Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol 47(2-3):89-94. Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S and Weller M (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 54(3):388-392. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K and Malik AB (2005) Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 289(3):L371-381. Ragel BT, Couldwell WT, Gillespie DL and Jensen RL (2007) Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev 30(3):181-187; discussion 187. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3(7):489-501. Robinson-Smith TM, Isaacsohn I, Mercer CA, Zhou M, Van Rooijen N, Husseinzadeh N, McFarland-Mancini MM and Drew AF (2007) Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res 67(12):5708-5716. Roggendorf W, Strupp S and Paulus W (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92(3):288-293. Rollins BJ, Morrison ED, Usher P and Flier JS (1988) Platelet-derived growth factor regulates glucose transporter expression. J Biol Chem 263(32):16523-16526. Rosales AA and Roque RS (1997) Microglia-derived cytotoxic factors. Part I: Inhibition of tumor cell growth in vitro. Brain Res 748(1-2):195-204. Rose DP, Gilhooly EM and Nixon DW (2002) Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 21(6):1285-1292. Rupp PA and Little CD (2001) Integrins in vascular development. Circ Res 89(7):566-572. Russo VC, Metaxas S, Kobayashi K, Harris M and Werther GA (2004) Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 145(9):4103-4112. Sader S, Nian M and Liu P (2003) Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation 108(6):644-646. Safavi-Abbasi S, Wolff JR and Missler M (2001) Rapid morphological changes in astrocytes are accompanied by redistribution but not by quantitative changes of cytoskeletal proteins. Glia 36(1):102-115. Salceda S and Caro J (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272(36):22642-22647. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D and Anania FA (2007) Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67(6):2497-2507. Schaffler A, Scholmerich J and Buechler C (2007) Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab 3(4):345-354. Schoch HJ, Fischer S and Marti HH (2002) Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125(Pt 11):2549-2557. Senaris R, Garcia-Caballero T, Casabiell X, Gallego R, Castro R, Considine RV, Dieguez C and Casanueva FF (1997) Synthesis of leptin in human placenta. Endocrinology 138(10):4501-4504. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219(4587):983-985. Sharp FR and Bernaudin M (2004) HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5(6):437-448. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC and Smithies O (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 93(23):13176-13181. Sica A, Allavena P and Mantovani A (2008) Cancer related inflammation: the macrophage connection. Cancer Lett 267(2):204-215. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ and Flores-Riveros JR (1998) Biological action of leptin as an angiogenic factor. Science 281(5383):1683-1686. Sistonen L, Holtta E, Lehvaslaiho H, Lehtola L and Alitalo K (1989) Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase. J Cell Biol 109(5):1911-1919. Smith-Kirwin SM, O'Connor DM, De Johnston J, Lancey ED, Hassink SG and Funanage VL (1998) Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 83(5):1810-1813. Sobel RA (1998) The extracellular matrix in multiple sclerosis lesions. J Neuropathol Exp Neurol 57(3):205-217. Sone H, Deo BK and Kumagai AK (2000) Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci 41(7):1876-1884. Storkebaum E, Lambrechts D and Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26(9):943-954. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM and Cheresh DA (2001) Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 155(3):459-470. Takakura Y, Trammel AM, Kuentzel SL, Raub TJ, Davies A, Baldwin SA and Borchardt RT (1991) Hexose uptake in primary cultures of bovine brain microvessel endothelial cells. II. Effects of conditioned media from astroglial and glioma cells. Biochim Biophys Acta 1070(1):11-19. Takata K, Kasahara T, Kasahara M, Ezaki O and Hirano H (1990) Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers. Biochem Biophys Res Commun 173(1):67-73. Tang CH, Lu DY, Yang RS, Tsai HY, Kao MC, Fu WM and Chen YF (2007) Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 pathway in microglia. J Immunol 179(2):1292-1302. Todaka M, Nishiyama T, Murakami T, Saito S, Ito K, Kanai F, Kan M, Ishii K, Hayashi H, Shichiri M and et al. (1994) The role of insulin in activation of two enhancers in the mouse GLUT1 gene. J Biol Chem 269(46):29265-29270. Trojan J, Cloix JF, Ardourel MY, Chatel M and Anthony DD (2007) Insulin-like growth factor type I biology and targeting in malignant gliomas. Neuroscience 145(3):795-811. Tumer N, Erdos B, Matheny M, Cudykier I and Scarpace PJ (2007) Leptin | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41344 | - |
dc.description.abstract | 神經膠細胞瘤(glioma)是中樞神經系統當中最常見也是最惡性的腫瘤。它最大的病理特色就是極容易從原生處侵犯到周圍的腦部組織,導致不論是手術後或是放射線治療後的預後不良。因此,研究神經膠細胞瘤的能量需求以及細胞轉移能力,或許能提供我們對於治療神經膠細胞瘤更多的了解。
腫瘤細胞相對於一般細胞而有較高的能量需求,包括攝入較多的葡萄糖、較旺盛的糖解作用、及較多的三磷酸腺苷產生,尤其是當腫瘤細胞缺乏足夠的氧氣供應時更為明顯。因為葡萄糖是由血液中轉運到腫瘤細胞內,所以葡萄醣分子勢必會經由血管內皮細胞及腫瘤細胞表面上的葡萄糖轉運蛋白來運送。在本論文中我們發現,當神經膠細胞瘤遭受缺氧刺激後會分泌一些調節因子,影響腦部血管內皮細胞上葡萄糖轉運蛋白的表現。從缺氧的成鼠神經膠細胞瘤細胞株(rat C6 glioma)所產生之條件性培養液(conditioned medium)會調增第一型葡萄糖轉運蛋白(glucose transporter type I)在成鼠腦血管內皮細胞株(adult rat brain endothelial cells)的表現;反之,在正常氧分壓下的成鼠神經膠細胞瘤細胞株所產生的條件性培養液則不會造成顯著影響。我們進一步發現,造成這樣顯著改變的原因來自於成鼠神經膠細胞瘤細胞株在缺氧狀況下所大量分泌的血管內皮生長因子(vascular endothelial growth factor)。當轉殖血管內皮生長因子的小干擾核醣核酸到大鼠神經膠細胞瘤細胞株中抑制其表現時,被轉殖細胞在缺氧刺激下產生的條件性培養液則無法如之前調增第一型葡萄糖轉運蛋白在成鼠腦血管內皮細胞株上的表現;再者,加入血管內皮生長因子的中和性抗體到缺氧下產生的條件性培養液中,也表現了類似的抑制作用。此外,在成鼠腦血管內皮細胞上經由血管內皮生長因子刺激所表現的第一型葡萄糖轉運蛋白,是經由磷脂酰肌醇-3激酶路徑所調控(PI3K/Akt)。這些結果顯示,受到缺氧刺激的神經膠細胞瘤會分泌血管內皮生長因子,進而促進葡萄糖轉運穿透過血腦屏障(blood-brain barrier)而由血流進入腫瘤細胞。 瘦素(Leptin)是一種肥胖基因的產物,它藉由調控代謝、進食、神經內分泌的反應來控制體重的維持。然而,中樞神經系統對於瘦素的基因表現和在週邊的脂肪細胞內不同。此外,瘦素被發現對於許多腫瘤細胞株有促進分裂和血管新生的作用。在此我們發現惡性的神經膠細胞瘤細胞株相較於其他非惡性的星狀神經膠細胞(astrocytes)會表現較多的瘦素及瘦素接受器,並發現當外給瘦素之後可刺激神經膠細胞瘤移行(migration)和侵犯週邊(invasion)的能力。此外我們發現在瘦素的刺激之下會增加第十三型基質金屬蛋白酶 (matrix metalloproteinase-13)在神經膠細胞瘤的表現,但第二型和第九型的表現則不受影響,且因瘦素而增加的移行和侵犯能力也會因為加入第十三型基質金屬蛋白酶的中和性抗體或小干擾核醣核酸而被抑制。此外,第十三型基質金屬蛋白酶的表現增加主要是經由瘦素的刺激後引起絲裂素活化蛋白激酶(p38 MAP kinase)和核轉錄因子NF-kappa B路徑的活化所造成。我們更進一步篩出較易移行的神經膠瘤細胞,並發現當細胞具有較強的移行能力時會表現較多的瘦素以及第十三型基質金屬蛋白酶。綜合以上的結果,我們發現瘦素會促進神經膠細胞瘤的移行和侵犯週邊的能力,而這樣的促進作用是來自於第十三型基質金屬蛋白酶的表現增加。 在腫瘤的微環境中,與發炎相關的調節因子或細胞受體扮演了相當重要的角色。在某些狀況下,致癌相關因子會引發出發炎的微環境且進而促進腫瘤的發展與惡化。在神經膠細胞瘤當中有微膠細胞(microglia)的存在,也表示了有與腫瘤相關的發炎現象、及微膠細胞的活化,且這些發炎反應會進而影響腫瘤生長與轉移的能力。在本論文中我們也發現,由神經膠細胞瘤所產生的胞外基質(extracellular matrix)可活化微膠細胞,並促使其分泌第十八型介白素(interleukin-18);這是一種屬於第一型介白素家族的細胞發炎激素(inflammatory cytokine),並可以刺激神經膠細胞瘤的移行能力。此外,藉由塗抹純化的胞外基質組成於培養盤表面而發現,微膠細胞在接觸到纖維粘連蛋白(fibronectin)與玻連蛋白(vitronectin)後會被活化而分泌出第十八型介白素;而第十八型介白素所引起的神經膠細胞瘤移行能力增加及細胞微絲重組(microfilament disassembly),皆會因為加入誘發型一氧化氮合成酶抑制劑(iNOS inhibitor)、鳥苷酸環化酶抑制劑(guanylate cyclase inhibitor)、G型蛋白質激酶抑制劑(protein kinase G)而被抑制。這些結果顯示,神經膠細胞瘤所產生的胞外基質會活化微膠細胞並促進其分泌第十八型介白素,且經由一氧化氮/環磷酸鳥苷(NO/cGMP)的路徑進而刺激神經膠細胞瘤的移行能力。 黏著分子(integrin)是另一個影響細胞移行和侵犯週邊能力的重要因子,它不只可以把細胞物理性的固定在基質上,並且還可以發送和接收調控這個機制的分子訊息;其中黏著分子alpha v beta 3會表現在血管內皮細胞和神經膠細胞瘤的細胞表面上。利用黏著分子的拮抗劑被認為可以經由數種機制去抑制腫瘤的進程。在本論文中我們發現,黏著分子拮抗劑專一性的阻斷黏著因子alpha v beta 3時,可具有抗血管新生的能力、及抑制神經膠細胞瘤細胞群落形成的能力。此外,因為瘦素被發現也會增加黏著分子alpha v和beta 3在神經膠細胞瘤上的表現,因此該黏著分子拮抗劑也會抑制瘦素所引發的細胞移行。 腦血管內皮細胞組成的血腦屏障藉由細胞間的緊密連接蛋白(tight junction protein)的隔離來維持腦部血管的低滲透性及維持腦內組成的平衡。缺血再灌流(Ischemia/Reperfusion)被認為會傷害血腦屏障並造成滲透性的改變,在此我們利用成鼠腦血管內皮細胞株探討YC-1的保護角色,防止化學性缺氧及缺氧再給氧(Hypoxia/Reoxygenation)所引發的血腦屏障滲透性改變。實驗發現YC-1會顯著的減少氯化鈷(CoCl2)和缺氧再給氧所造成的葡萄聚醣(fluorescein isothiocyanate-dextran)滲透度增加。此外,構成血腦屏障的緊密連接蛋白之一ZO-1(zonular occludens-1)會因為氯化鈷和缺氧再給氧的刺激而被破壞,且此現象會因為加入YC-1而被拮抗。進一步的實驗發現,YC-1的保護作用可能來自於抑制第一型缺氧誘導因子(hypoxia-inducible factor-1)在細胞內的累積,並進而減少其下游的血管內皮生長因子的蛋白表現。血管內皮生長因子單獨作用即可顯著增加葡萄聚醣的滲透度,並且調降成鼠腦血管內皮細胞株上ZO-1的表現。我們進一步用動物實驗來評估,發現在缺血再灌流之後YC-1可有效的防止缺血再灌流對於血腦屏障所造成的傷害。總體而言,YC-1可能藉由抑制第一型缺氧誘導因子在細胞內的累積,進一步減少血管內皮生長因子的表現,並進而保護血腦屏障不受到缺氧所造成的傷害。 神經膠細胞瘤於成人造成很高的死亡率,原因在於它很容易在不知不覺間轉移侵犯到周圍組織、腫瘤邊界不明顯,造成治療效果不彰。本論文從腫瘤細胞能量代謝及發炎的角度來探討並了解其影響癌細胞轉移的能力;此外,更初步評估一個新的發展中藥物黏著分子拮抗劑在神經膠細胞瘤方面的應用,以期能開發藥物治療神經膠細胞瘤的方針。 | zh_TW |
dc.description.abstract | Glioblastoma multiform (GBM) is the most frequent and malignant tumor of the central nervous system (CNS). The pathological characteristic of their insidious infiltration of the brain leads to the poor prognosis after surgery and/or radiation therapy. Therefore, elucidation of the energy demand and motility of glioma provides more information to develop potential therapeutic targets.
Increased need for glycolysis and glucose uptake for ATP production is observed in tumor cells, particularly in cells lacking of oxygen supply. Because glucose is transported from blood to tumor, glucose molecules must be delivered across glucose transporters of the vascular endothelium and tumor cells. Here we found that glioma suffered from hypoxic insults can secrete factor(s) to regulate glucose transporter expression in brain endothelium. It was found that conditioned medium from rat C6 glioma cells under hypoxia up-regulated glucose transporter type 1 (GLUT1) expression in rat brain endothelial cells, whereas conditioned medium from C6 cells under normoxia caused no significant effect. We further investigated whether the observed potentiating effect was caused by vascular endothelial growth factor (VEGF) production from C6 cells, because secreted VEGF was markedly increased under hypoxic condition. By transfection of C6 cells with VEGF small interfering RNA, it was found that conditioned medium from transfected cells under hypoxia no longer up-regulated GLUT1 expression of endothelial cells. Moreover, the addition of VEGF-neutralizing antibody to the hypoxic conditioned medium could also exert similar inhibitory effects. Furthermore, it was found that the VEGF-induced increase of GLUT1 expression in endothelial cells was mediated by the phosphoinositide-3 kinase/Akt pathway. Our results indicate that hypoxic brain glioma may secrete VEGF to increase glucose transport across blood-brain barrier (BBB). Leptin, the product of the obese gene, plays an important role in the regulation of body weight by coordinating metabolism, feeding behavior, energy balance, and neuroendocrine responses. However, regulation of leptin gene expression in the CNS is different from that in the adipocytes. In addition, leptin has been found in many tumor cell lines and has been shown to have mitogenic and angiogenic activity in a number of cell types. Here we found that malignant C6 glioma cells expressed more leptin and leptin receptors than nonmalignant astrocytes. Furthermore, it was found that exogenous application of leptin enhanced the migration and invasion of C6 glioma cells. In addition, we found that the expression of matrix metalloproteinase-13 (MMP-13) but not of MMP-2 and MMP-9 was increased in response to leptin stimulation. The leptin-induced increase of cell migration and invasion was antagonized by MMP-13 neutralizing antibody or silencing MMP-13. The up-regulation of MMP-13 induced by leptin was mainly through p38 MAP kinase and NF-kappa B pathway. In addition, migration-prone sublines demonstrate that cells with increasing migration ability had more expression of MMP-13 and leptin. Taken together, these results indicate that leptin enhanced migration and invasion of C6 glioma cells through the increase of MMP-13 production. The mediators and cellular effectors of inflammation are important constituents of the local environment of tumors. In some occasions, oncogenic changes induce an inflammatory microenvironment that promotes the progression of tumors. In gliomas, the presence of microglia may represent tumor-related inflammation and microglia activation, and subsequent inflammatory responses may influence tumor growth and metastasis. Here we found that C6 glioma- but not primary astrocyte-derived extracellular matrix (ECM) could activate microglia, including primary microglia and BV-2 cell line, and activated microglia secreted interleukin (IL)-18, a potent inflammatory cytokine of the IL-1 family, to promote C6 migration. In addition, by coating purified ECM components, it was found that secretion of IL-18 by activated microglia was enhanced when microglia encountered with fibronectin and vitronectin. Furthermore, IL-18-induced C6 migration and microfilament disassembly were antagonized by iNOS inhibitor, guanylate cyclase (GC) inhibitor and protein kinase G (PKG) inhibitor. Taken together, these results indicate that IL-18 secreted by microglia, which was activated by C6 glioma-derived ECM, enhanced migration of C6 glioma through NO/cGMP pathway. Integrins play another crucial role for cell invasion and migration, not only for physically tethering cells to the matrix, but also for sending and receiving molecular signals that regulate these processes. Pharmacological blockade of integrins using integrin antagonists are considered to inhibit tumor progression by several mechanisms. Here we found an alpha v beta 3-selective integrin antagonist exhibited an anti-angiogenic effect in vivo and inhibits colony formation of C6 glioma cells. Moreover, since leptin also up-regulated integrin alpha v and beta 3 expression in C6 glioma, this integrin antagonist also antagonized leptin-induced C6 migration. Cerebral microvascular endothelial cells form the anatomical basis of the BBB, and the tight junctions of the BBB are critical for maintaining brain homeostasis and low permeability. Ischemia/reperfusion is known to damage the tight junctions of BBB and lead to permeability changes. Here we investigated the protective role of 3-(5’-hydroxymethyl-2’-furyl)-1-benzylindazole (YC-1), against chemical hypoxia and hypoxia/reoxygenation (H/R)-induced BBB hyperpermeability using adult rat brain endothelial cell culture (ARBEC). YC-1 significantly decreased CoCl2- and H/R-induced hyperpermeability of fluorescein isothiocyanate (FITC)-dextran in cell culture inserts. It was found that the decrease and disorganization of tight junction protein zonular occludens-1 (ZO-1) in response to CoCl2, and H/R was antagonized by YC-1. The protection of YC-1 may result from the inhibition of HIF-1 alpha accumulation and production of its downstream target VEGF. VEGF alone significantly increased FITC-dextran permeability and down-regulated mRNA and protein levels of ZO-1 in ARBECs. We further used animal model to examine the effect of YC-1 on BBB permeability after cerebral ischemia/reperfusion. It was found that YC-1 significantly protected the BBB against ischemia/reperfusion-induced injury. Taken together, these results indicate that YC-1 may inhibit HIF-1 alpha accumulation and VEGF production, which in turn protect BBB from injury caused by hypoxia. Glioblastoma multiforme is the most common malignant glioma in adults. GBM constitutes a major problem in clinical management due to its high infiltrative ability, resistance to the current cancer therapy that account for its bad prognosis and high mortality. In our studies, we investigated tumor cell motility from the aspects of energy demand and tumor-related inflammation. Moreover, we also evaluated the anti-angiogenic and anti-tumor effects of a developing integrin antagonist for becoming a good candidate to treat glioblastoma. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T00:16:18Z (GMT). No. of bitstreams: 1 ntu-98-F93443001-1.pdf: 10162369 bytes, checksum: adb9fe90c1f5fec37cf9d2d6d5ca8868 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | Content
Page Abbreviations 1 Abstract in Chinese 7 Abstract in English 13 1. Introduction 21 1-1. Tight junctions and glucose transporters of brain endothelium 23 1-2. Hypoxic insults and functions of VEGF 35 1-3. The role of MMPs in tumor cell motility 45 1-4. Interaction between microglia and glioma 53 1-5. The function of integrin in angiogenesis and tumor progression 60 1-6. The pharmaceutical role of YC-1 74 2. Materials and Methods 77 3. In Vitro Studies of Energy Demand and Cell Motility in Glioma 103 3-1. Enhance of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia 105 3-2. Leptin induces migration and invasion of glioma cells through MMP-13 production 122 3-3. A forward loop between glioma and microglia: Glioma-derived extracellular matrix-activaed microglia secrete IL-18 to enhance the migration of glioma cells 142 4. Inhibiting Effects of Integrin alpha v beta 3 Antagonist on Cancer Progression 163 5. Inhibition of Hypoxia-Induced Increase of Blood-Brain Barrier Permeability by YC-1 177 6. Conclusion and Perspective 203 Reference 209 Publications and Honors 227 | |
dc.language.iso | en | |
dc.title | 細胞移行與能量需求在神經膠細胞瘤的探討 | zh_TW |
dc.title | Studies of Tumor Cell Motility and Energy Demand in Glioma | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 鄧哲明,楊春茂,顏茂雄,郭明良 | |
dc.subject.keyword | 神經膠細胞瘤,細胞移行,能量需求, | zh_TW |
dc.subject.keyword | glioma,migration,energy, | en |
dc.relation.page | 231 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-06-05 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 9.92 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。